Devanand Sarkar
Impact in
- Oncology top 0.5%
- Cytokine Signaling Pathways and Interactions
- Biotechnology top 0.2%
- Cancer Research and Treatments
Papers in
-
- Cancer Mechanisms and Therapy 58
- Oncology 70
- Cytokine Signaling Pathways and Interactions 20
- Cancer-related Molecular Pathways 18
- Co-authors
- Paul B. Fisher (251 shared papers)Zao-zhong Su (41 shared papers)Luni Emdad (88 shared papers)Swadesh Kumar Das (103 shared papers)Paul Dent (72 shared papers)Luni Emdad (38 shared papers)Irina V. Lebedeva (40 shared papers)Seok‐Geun Lee (22 shared papers)
- Journals
- Cancer Research (33 papers)Advances in cancer research (26 papers)Proceedings of the National Academy of Sciences (23 papers)Journal of Cellular Physiology (22 papers)Oncogene (13 papers)
- Partner nations
- United StatesSouth KoreaIndia
In The Last Decade
Devanand Sarkar
309 papers receiving 18.8k citations
Devanand Sarkar's Hit Papers
Peers
Comparison fields: 5 of 140
- Oncology 3.3k
- Biotechnology 955
- Cancer Research 1.9k
- Pathology and Forensic Medicine 2.3k
- Immunology 2.4k
Countries citing papers authored by Devanand Sarkar
This map shows the geographic impact of Devanand Sarkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devanand Sarkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devanand Sarkar more than expected).
Fields of papers citing papers by Devanand Sarkar
This network shows the impact of papers produced by Devanand Sarkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devanand Sarkar. The network helps show where Devanand Sarkar may publish in the future.
Co-authors
The 25 scholars most cited alongside Devanand Sarkar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 315 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | I nterleukin -10 and R elated C ytokines and R eceptors Hit paper breakdown → | 2004 | 954 |
| 2 | Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification Hit paper breakdown → | 2020 | 636 |
| 3 | 2013 | 473 | |
| 4 | 2010 | 342 | |
| 5 | 2005 | 304 | |
| 6 | 2009 | 294 | |
| 7 | 2012 | 276 | |
| 8 | 2002 | 275 | |
| 9 | 2008 | 266 | |
| 10 | 2005 | 256 | |
| 11 | Emerging Therapies for Hepatocellular Carcinoma (HCC) Hit paper breakdown → | 2022 | 255 |
| 12 | 2006 | 252 | |
| 13 | 2011 | 242 | |
| 14 | 2012 | 227 | |
| 15 | 2008 | 215 | |
| 16 | 2014 | 209 | |
| 17 | 2006 | 200 | |
| 18 | 2007 | 194 | |
| 19 | 2013 | 189 | |
| 20 | 2003 | 177 |
About Devanand Sarkar
Devanand Sarkar is a scholar working on Pathology and Forensic Medicine, Oncology, Biotechnology, Hepatology and Immunology, having authored 315 papers that have together received 19.2k indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (58 papers), Virus-based gene therapy research (40 papers), Cell death mechanisms and regulation (28 papers), Cancer Research and Treatments (27 papers), Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Glioma Diagnosis and Treatment (21 papers), Cytokine Signaling Pathways and Interactions (20 papers) and Cancer-related Molecular Pathways (18 papers). The work is most often cited by research in Oncology (3.3k citations), Biotechnology (955 citations), Cancer Research (1.9k citations), Pathology and Forensic Medicine (2.3k citations) and Immunology (2.4k citations). Devanand Sarkar has collaborated with scholars based in United States, South Korea and India. Frequent co-authors include Paul B. Fisher, Zao-zhong Su, Luni Emdad, Swadesh Kumar Das, Paul Dent, Luni Emdad, Irina V. Lebedeva, Seok‐Geun Lee, Saranya Chidambaranathan Reghupaty and Xiang‐Yang Wang. Their work appears in journals such as Cancer Research, Advances in cancer research, Proceedings of the National Academy of Sciences, Journal of Cellular Physiology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.